Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

All three mein components of the substance PGMC, namely 2-hydroxypropyl octanoate, propylene glycol 2-caprylate, propylene-1,2-dioctanoate, 1,2 propanediol, 1,3 propanediol and caprylic acid are considered NEGATIVE for Bacterial Mutagenicity.

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
(Q)SAR
Adequacy of study:
key study
Study period:
2021
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
Justification for type of information:
1. SOFTWARE
Various tools, inter alia CASE Ultra, DEREK Nexus, OECD Toolbox, ToxRead, Toxtree, VEGA

2. MODEL (incl. version number)

Model Version Approach
CASE Ultra 1.8.0.2 Statistical/Expert
DEREK Nexus 6.0.1 Expert
OECD (Q)SAR Toolbox 4.4.1 Expert/Read-across
ToxRead 0.23beta Read-across
Toxtree 3.1.0 Expert
VEGA 1.1.5_b36 Hybrid

3. SMILES OR OTHER IDENTIFIERS USED AS INPUT FOR THE MODEL
Main components of the substance:

1) CCCCCCCC(=O)OCC(C)O
2) CCCCCCCC(=O)OC(C)CO
3) CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC

Impurities (=educts) of the substance
4) CC(O)CO
5) OCCCO
6) CCCCCCCC(=O)O

4. SCIENTIFIC VALIDITY OF THE (Q)SAR MODEL
See attached QMRF/ QPRF Report

5. APPLICABILITY DOMAIN
See attached QMRF/ QPRF Report

6. ADEQUACY OF THE RESULT
See attached QMRF/ QPRF Report
Reason / purpose for cross-reference:
reference to same study
Principles of method if other than guideline:
- Principle of test:, Short description of test conditions, Parameters analysed / observed:
Model Version Approach
CASE Ultra 1.8.0.2 Statistical/Expert
DEREK Nexus 6.0.1 Expert
OECD (Q)SAR Toolbox 4.4.1 Expert/Read-across
ToxRead 0.23beta Read-across
Toxtree 3.1.0 Expert
VEGA 1.1.5_b36 Hybrid
GLP compliance:
no
Type of assay:
other: QSAR
Remarks on result:
no mutagenic potential (based on QSAR/QSPR prediction)

Consensus results for in vitro mutagenicity from statistical-based models with reliability scores, s+/-, and weighted reliability scores, s+/-w (for details, please refer to appendix)

Model

Pred result (+/-)

s+/-

Exp result (+/-)

s+/-·w

Pred result (+/-)

s+/-

Exp result (+/-)

s+/-·w

2-hydroxypropyl octanoate

1,2 propanediol

CASE Ultra

-

1

0.2

-

2

 

1.2

CAESAR

-

2

1.2

-

3

-

3

ISS

-

3

2.7

-

3

 

2.7

SarPy

-

2

1.2

-

3

-

3

KNN

-

3

2.7

-

3

 

2.7

Consensus score Mutagenicity

0.00

 

 

 

0.00

Consensus score Non-Mutagenicity

0.53

 

 

 

1.00

Propylene glycol 2-caprylate

1,3 propanediol

CASE Ultra

-

3

2.7

-

2

-

3

CAESAR

-

2

1.2

-

3

 

2.7

ISS

-

3

2.7

-

2

 

1.2

SarPy

-

2

1.2

-

3

 

2.7

KNN

-

3

2.7

-

3

 

2.7

Consensus score Mutagenicity

0.00

 

 

 

0.00

Consensus score Non-Mutagenicity

0.70

 

 

 

1.00

Propylene-1,2-dioctanoate

Caprylic acid

CASE Ultra

-

3

2.7

-

3

-

3

CAESAR

-

3

2.7

-

3

-

3

ISS

-

3

2.7

-

3

 

2.7

SarPy

-

3

2.7

-

3

-

3

KNN

-

2

1.2

-

3

-

3

Consensus score Mutagenicity

0.00

 

 

 

0.00

Consensus score Non-Mutagenicity

0.80

 

 

 

1.00

CASE Ultra predictions results and probability values for chromosomal aberration, micronucleus and mouse lymphoma test

Chromosomal aberrations,in vitro, CHL cell line

Chromosomal aberrations,in vitro, CHO cell line

Micronucleus test,in vivo, mouse

Mouse Lymphoma, activated

Mouse Lymphoma, unactivated

Result

Prob

Result

Prob

Result

Prob

Result

Prob

Result

Prob

2-hydroxypropyl octanoate

Negative

27.2

Negative

27.6

Negative

32.5

Negative

26.7

Negative

29.4

Propylene glycol 2-caprylate

Negative

27.2

Negative

27.6

Negative

32.5

Negative

26.7

Inconclusive

52.8

Propylene-1,2-dioctanoate

Negative

27.2

Negative

27.6

Negative

32.5

Negative

26.7

Negative

29.4

1,2 propanediol

known Negative

27.2

Negative

27.6

Negative

32.5

Negative

26.7

Inconclusive

52.8

1,3 propanediol

Negative

27.2

Negative

27.6

Negative

32.5

Negative

26.7

Negative

29.4

Caprylic acid

Negative

27.2

Negative

27.6

Negative

32.5

Negative

26.7

Negative

29.4

Result of read-across assessment for mutagenicity with ToxRead

Impurity/Metabolite

Non-mutagenicity score

Mutagenicity score

Read-across assessment

2-hydroxypropyl octanoate

0.95

0.05

Non-mutagenic

Propylene glycol 2-caprylate

0.94

0.06

Non-mutagenic

Propylene-1,2-dioctanoate

1.00

0.00

Non-mutagenic

1,2 propanediol

1.00

0.00

Non-mutagenic

1,3 propanediol

1.00

0.00

Non-mutagenic

Caprylic acid

1.00

0.00

Non-mutagenic

Conclusions:
All components of the substance PGMC are considered to be non-mutagenic
Executive summary:

No alert for mutagenicityin vitroin bacterium was identified for the six query compounds with DEREK and the expert system concluded mutagenicityin vitroin bacterium is INACTIVE (Table2). Moreover, no misclassified or unclassified features were detected which indicates confidence in the predictions.

No expert alerts were identified with the rule-based expert system GT_EXPERT of CASE Ultra and the six query compounds were predicted to be NEGATIVE in the bacterial in vitro mutagenicity test forS. typhimuriumandE. coliassays (Table2).

Rule-based read-across platform ToxRead identified only structural alerts for non-mutagenicity (Table2) and predicted all query compounds to be NON-MUTAGENIC in the Ames mutagenicity test (Table5).

2-hydroxypropyl octanoate, propylene glycol 2-caprylate, propylene-1,2-dioctanoate and 1,2 propanediol have a structural alert forin vivomutagenicity in OECD Toolbox (Table2). Thein vivomutagenicity (micronucleus) alert explores the possibility that a chemical interacts with DNA and/or proteins via non-covalent binding, such as DNA intercalation or groove-binding‎[11]. The percentage of true positives for this alert was low as only 34% of the substances that generate this alert tested positive for this mutagenic pathway (i.e., 55 substances tested positive of the 163 substances with this alert in the original analysis conducted by Benigni et al.‎[12]). In another study 28 structural alerts of the six mutagenicity profiler in OECD Toolbox were found to be too inaccurate to be used as an indicator for mutagenicity, of which “Hacceptor-path3-Hacceptor” in the micronucleus profiler was the highest triggered alert. The positive predictivity of this alert was 30% (i.e. 323 substances tested positive of the 1114 with this alert)‎[13]. Thus, the presence of this alert is not necessarily a strong indicator of effects. In addition, 1,2 propanediol was reported negative in the micronucleus assay‎[14], providing sufficient information to suggest this compound is unlikely to cause mutagenicity through the alert identified by the ISS profiler forin vivomutagenicity. Further, negative prediction results for chromosomal aberration, micronucleus and mouse lymphoma test indicate all query compounds to be not clastogenic and/or aneugenic (Table4). In our expert opinion, the domain of this alert is not well defined and the alert has a very weak support for mutagenicity. That makes the alertof context for the purpose of this investigation and suggests dismissing its finding as insignificant.

Additional information

Justification for classification or non-classification